• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Trial of tamoxifen at a dose of 40 mg daily after disease progression during tamoxifen therapy at a dose of 20 mg daily.

作者信息

Stewart J F, Minton M J, Rubens R D

出版信息

Cancer Treat Rep. 1982 Jun;66(6):1445-6.

PMID:7044536
Abstract
摘要

相似文献

1
Trial of tamoxifen at a dose of 40 mg daily after disease progression during tamoxifen therapy at a dose of 20 mg daily.
Cancer Treat Rep. 1982 Jun;66(6):1445-6.
2
Clinical pharmacology of tamoxifen in patients with breast cancer: comparison of traditional and loading dose schedules.他莫昔芬在乳腺癌患者中的临床药理学：传统给药方案与负荷剂量方案的比较
Cancer Treat Rep. 1980 Jun-Jul;64(6-7):765-73.
3
[Results of phase II clinical trial of Tamoxifen and Toremifen in two different doses in advanced breast cancer in postmenopausal women].[他莫昔芬和托瑞米芬两种不同剂量用于绝经后妇女晚期乳腺癌的II期临床试验结果]
Vopr Onkol. 1997;43(6):587-95.
4
Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.全反式维甲酸与他莫昔芬用于晚期乳腺癌患者的I/II期试验。
Clin Cancer Res. 1998 Mar;4(3):635-42.
5
Efficacy of tamoxifen as treatment of breast cancer.
Semin Oncol. 1997 Feb;24(1 Suppl 1):S1-48-S1-54.
6
[A randomized, double-blind, placebo-controlled, phase 3 trial comparing SMS 201-995 pa LAR plus tamoxifen versus tamoxifen plus placebo in women with locally recurrent or metastatic breast cancer].一项随机、双盲、安慰剂对照的3期试验，比较SMS 201-995 pa LAR联合他莫昔芬与他莫昔芬联合安慰剂治疗局部复发或转移性乳腺癌女性的疗效
Zentralbl Gynakol. 2001 Oct;123(10):557-61. doi: 10.1055/s-2001-19088.
7
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial.阿那曲唑与他莫昔芬作为绝经后激素受体阳性乳腺癌女性术前治疗的比较：术前“瑞宁得”与他莫昔芬对比（PROACT）试验
Cancer. 2006 May 15;106(10):2095-103. doi: 10.1002/cncr.21872.
8
Clinical inquiries. Does tamoxifen prevent breast cancer?临床问题。他莫昔芬能预防乳腺癌吗？
J Fam Pract. 2001 Dec;50(12):1023.
9
Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial.与单纯使用他莫昔芬相比，表柔比星联合他莫昔芬每周给药作为可手术、淋巴结阳性老年乳腺癌患者辅助治疗的无病生存优势：法国辅助治疗研究组08试验的6年随访结果
J Clin Oncol. 2004 Dec 1;22(23):4622-30. doi: 10.1200/JCO.2004.02.145. Epub 2004 Oct 25.
10
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.对于完成5年他莫昔芬治疗的早期乳腺癌女性患者，来曲唑的晚期延长辅助治疗可改善其预后。
J Clin Oncol. 2008 Apr 20;26(12):1948-55. doi: 10.1200/JCO.2007.11.6798. Epub 2008 Mar 10.

引用本文的文献

1
Tamoxifen as adjuvant therapy in breast cancer. Current status.他莫昔芬作为乳腺癌辅助治疗的现状
Drugs. 1993 Nov;46(5):819-33. doi: 10.2165/00003495-199346050-00003.
2
A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd.两种剂量他莫昔芬（诺瓦得士）治疗绝经后晚期乳腺癌女性的比较：每日两次，每次10毫克与每日两次，每次20毫克。
Br J Cancer. 1984 Aug;50(2):199-205. doi: 10.1038/bjc.1984.163.
3
The value of high dose tamoxifen in postmenopausal breast cancer patients progressing on standard doses: a pilot study.
高剂量他莫昔芬对标准剂量治疗后病情进展的绝经后乳腺癌患者的价值：一项初步研究。
Br J Cancer. 1988 Mar;57(3):320-1. doi: 10.1038/bjc.1988.72.
4
On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.关于他莫昔芬、醋酸甲羟孕酮和氨鲁米特联合激素单一疗法在晚期乳腺癌中的作用
Klin Wochenschr. 1987 Oct 15;65(20):959-66. doi: 10.1007/BF01717830.
5
Tamoxifen metabolism: pharmacokinetic and in vitro study.他莫昔芬代谢：药代动力学及体外研究
Br J Cancer. 1989 Jul;60(1):30-5. doi: 10.1038/bjc.1989.214.
6
Endocrine therapy of metastatic breast cancer.转移性乳腺癌的内分泌治疗
J Endocrinol Invest. 1989 May;12(5):357-72. doi: 10.1007/BF03350007.